Advanced Manufacturing Investors & VC Firms in Asia-Pacific
477 firms in this list, with a median first check of $500K. 96 of them lead rounds. Generated from verified public data and updated continuously.
Celesta Capital
San MateoPre-Seed–Series C$5M – $10M
26 people
Northleaf Capital Partners
TorontoGrowth
67 people
Metaplanet
TallinnSeed–Series B$500K – $10M
5 people
Ventech
ParisSeed–Series C$540K – $5.4M
34 people
Apollo Asset Management
New YorkGrowth–Late Stage
53 people
Eurazeo
ParisSeed–Late Stage
35 people
Hitachi Ventures
MunichSeed–Late Stage
34 people
GoAhead Ventures
Menlo ParkPre-Seed–Seed$500K – $1M
12 people
Foresight Group
LondonSeed–Growth$2.6M – $52M
41 people
SCF Partners
Houston
33 people
Investcorp
ManamaSeries A–Growth
13 people
Platinum
Los AngelesGrowth–Late Stage$100M – $10B
30 people
SE Ventures
Menlo ParkPre-Seed–Series B
24 people
Baillie Gifford
EdinburghSeries B–Late Stage
15 people
The Westly Group
Menlo ParkPre-Seed–Growth$500K – $15M
22 people
Invest Northern Ireland
BelfastPre-Seed–Seed
30 people
EBRD
LondonSeries B
39 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
Washington Harbour Partners
ArlingtonSeries A–Late Stage
25 people
Impact Fund Denmark
Copenhagen$2.2M – $70.2M
39 people
Foundamental
San FranciscoPre-Seed–Series B$500K – $5M
15 people
Souter Investments
EdinburghGrowth$2.5M – $38M
13 people
Zero Infinity Partners
New YorkPre-Seed–Series A$100K – $5M
16 people
U.S. International Development Finance Corporation (DFC)
WashingtonGrowth
37 people
Related lists
Investors & VC Firms in North America (13118)Investors & VC Firms in United States (12145)Investors & VC Firms in Europe (5954)AI & Machine Learning Investors & VC Firms (5127)Investors & VC Firms in Global (5099)Fintech Investors & VC Firms (4949)Healthtech Investors & VC Firms (4486)SaaS Investors & VC Firms (4408)Enterprise Software Investors & VC Firms (4306)Crypto & Web3 Investors & VC Firms (4087)
Data sourced from public filings and firms' own websites — see our methodology.















































































































